Akebia Therapeutics to Participate in the Piper Sandler 34th Annual Healthcare Conference

Rhea-AI Summary

Akebia Therapeutics, Inc. (Nasdaq: AKBA) announced its participation in the Piper Sandler 34th Annual Healthcare Conference, scheduled for November 29 to December 1, 2022, in New York City. CEO John P. Butler will engage in a fireside chat on November 29 at 2:30 p.m. ET. A webcast of this session will be accessible for 90 days via the Investors section of Akebia's website. Founded in 2007 and headquartered in Cambridge, Massachusetts, Akebia focuses on developing therapeutics for kidney disease.

CAMBRIDGE, Mass., Nov. 22, 2022 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the company will participate in the Piper Sandler 34^th Annual Healthcare Conference, which takes place November 29-December 1, 2022 in New York City, New York.

John P. Butler, Chief Executive Officer of Akebia Therapeutics, will participate in a fireside chat on Tuesday, November 29 at 2:30 p.m. ET.

A webcast of the fireside chat will be available through the Investors section of Akebia's website at https://ir.akebia.com for approximately 90 days following the conference.

About Akebia Therapeutics 
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact 
Mercedes Carrasco 
Mcarrasco@akebia.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference-301685166.html

SOURCE Akebia Therapeutics

FAQ

When is Akebia Therapeutics participating in the Piper Sandler Healthcare Conference?

Akebia Therapeutics will participate in the Piper Sandler Healthcare Conference from November 29 to December 1, 2022.

Who from Akebia Therapeutics will speak at the conference?

CEO John P. Butler will participate in a fireside chat on November 29 at 2:30 p.m. ET.

Where can I watch the Akebia Therapeutics conference webcast?

The webcast will be available on the Investors section of Akebia's website for approximately 90 days following the conference.

What is Akebia Therapeutics focused on?

Akebia Therapeutics focuses on developing and commercializing therapeutics for people living with kidney disease.